+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A microRNA biomarker panel for the non-invasive detection of bladder cancer

A microRNA biomarker panel for the non-invasive detection of bladder cancer

Oncotarget 7(52): 86290-86299

The development of accurate, non-invasive urinary assays for bladder cancer would greatly facilitate the detection and management of a disease that has a high rate of recurrence and progression. In this study, we employed a discovery and validation strategy to identify microRNA signatures that can perform as a non-invasive bladder cancer diagnostic assay. Expression profiling of 754 human microRNAs (TaqMan low density arrays) was performed on naturally voided urine samples from a cohort of 85 subjects of known bladder disease status (27 with active BCa). A panel of 46 microRNAs significantly associated with bladder cancer were subsequently monitored in an independent cohort of 121 subjects (61 with active BCa) using quantitative real-time PCR (RT-PCR). Multivariable modeling identified a 25-target diagnostic signature that predicted the presence of BCa with an estimated sensitivity of 87% at a specificity of 100% (AUC 0.982). With additional validation, the monitoring of a urinary microRNA biomarker panel could facilitate the non-invasive evaluation of patients under investigation for BCa.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 057070142

Download citation: RISBibTeXText

PMID: 27863434

Related references

Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. European Urology 63(6): 1091-1100, 2013

Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer. Oncology Letters 15(6): 9584-9592, 2018

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer. Korean Journal of Urology 54(11): 791-796, 2013

Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection. Disease Markers 2018: 5609395, 2018

Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer. Oncology Reports 39(3): 1338-1346, 2017

A candidate molecular biomarker panel for the detection of bladder cancer. Cancer Epidemiology, Biomarkers and Prevention 21(12): 2149-2158, 2013

Plasma microRNA panel for minimally invasive detection of breast cancer. Plos One 8(10): E76729, 2015

Urinary protein biomarker panel for the detection of recurrent bladder cancer. Cancer Epidemiology, Biomarkers and Prevention 23(7): 1340-1345, 2015

Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer. Medical Oncology 31(10): 197, 2015

Comprehensive and integrative analysis identifies microRNA-106 as a novel non-invasive biomarker for detection of gastric cancer. Journal of Translational Medicine 16(1): 127, 2018

Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. Bmc Cancer 15: 193, 2016

Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clinical Cancer Research 12(7 Pt 1): 2109-2116, 2006

Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?. Translational Andrology and Urology 7(Suppl 1): S109-S110, 2018

Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer. Biomarkers 22(7): 674-681, 2016

Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel. European Urology Focus 2018, 2018